Skip to main content
. 2023 Aug 19;78(10):2471–2480. doi: 10.1093/jac/dkad256

Figure 1.

Figure 1.

Study schematic. Time period (<96 h) to complete eligibility assessments started at the time that the sample for the blood culture positive for Candida was collected. EOST may be the same as EOT for those participants who do not step-down to fluconazole or alternative antifungal therapy. EOST, end of study treatment; EOT, end of treatment; FMGX, fosmanogepix; IV, intravenous; PO, oral.